Bryan T Mayer

17PUBLICATIONS
105CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityGenetic immunologyNanomedicineBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 28, 2026
Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials.

|Jul 07, 2026
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Jul 05, 2025
Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.

Yunda Huang, Bo Zhang, Lily Zhang

|Jun 12, 2025
Engineering Sustained-Release Broadly Neutralizing Antibody Formulations.

Carolyn K Jons, Catherine M Kasse, Bryan T Mayer

|Nov 11, 2024
A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions.

Sedem Dankwa, Christina Kosman, Maria Dennis

Pageof 3

Frequent Collaborators

7 joint publications

Yunda Huang

6 joint publications

David Montefiori

6 joint publications

Daniel B Reeves

5 joint publications

Michal Juraska